These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
3. [Non-steroidal anti-inflammatory agents (NSAID's) with lesser side effects by selective inhibition of cyclo-oxygenase-2]. Bijlsma JW; Van de Putte LB Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1762-5. PubMed ID: 9856140 [TBL] [Abstract][Full Text] [Related]
4. Treatment of rheumatic diseases in the elderly. Luggen M Geriatr Nurs; 2001; 22(3):118-9. PubMed ID: 11410761 [No Abstract] [Full Text] [Related]
5. NSAIDs and alcohol: never the twain shall mix? Pfau PR; Lichenstein GR Am J Gastroenterol; 1999 Nov; 94(11):3098-101. PubMed ID: 10566697 [No Abstract] [Full Text] [Related]
6. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523 [TBL] [Abstract][Full Text] [Related]
7. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?]. Kankaanranta H; Vapaatalo H Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604 [No Abstract] [Full Text] [Related]
8. Non steroidal anti-inflammatory drugs, cyclooxygenase selectivity and gastrointestinal toxicity. Jacob M; Simpson R; Bjarnason I Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):12-8. PubMed ID: 9615258 [No Abstract] [Full Text] [Related]
9. Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs. Albu R; Dragomir P; Voiosu R Rom J Intern Med; 1998; 36(3-4):145-59. PubMed ID: 10822511 [TBL] [Abstract][Full Text] [Related]
10. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit. Hawkey CJ Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265 [No Abstract] [Full Text] [Related]
11. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer]. Wei WQ; Qiao YL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826 [TBL] [Abstract][Full Text] [Related]
12. The use of NSAIDs in rheumatic disorders 2005: a global perspective. Kean WF; Buchanan WW Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389 [TBL] [Abstract][Full Text] [Related]
13. New NSAIDs--inhibitors of cyclooxygenase 2--and renal damage. Navarro JF; Mora C; García J Br J Rheumatol; 1996 Dec; 35(12):1332. PubMed ID: 9010074 [No Abstract] [Full Text] [Related]
14. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Price-Forbes AN; Callaghan R; Allen ME; Rowe IF Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035 [TBL] [Abstract][Full Text] [Related]
16. Aspirin and NSAID sensitivity. Stevenson DD Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723 [TBL] [Abstract][Full Text] [Related]
17. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea. Lee MC; Lee S; Suh DC; Kim J; Kong SX; Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981 [TBL] [Abstract][Full Text] [Related]
18. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. Weir MR; Sperling RS; Reicin A; Gertz BJ Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311 [TBL] [Abstract][Full Text] [Related]